Cost-effectiveness of integrated disease management for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease in a primary care setting

Cost-effectiveness of integrated disease management for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease in a primary care setting

Highlights I. Interventions that can reduce the frequency and severity of exacerbations in patients who suffer from COPD have the potential to reduce the financial burden of COPD on the health system; II. This is the first study that demonstrates the cost-effectiveness of integrated disease manageme...

Full description

Bibliographic Details
Main Authors: Andrew D. Scarffe, Christopher J. Licskai, Madonna Ferrone, Kevin Brand, Kednapa Thavorn, Doug Coyle
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Cost Effectiveness and Resource Allocation
Subjects:
COPD
Chronic obstructive pulmonary disease
Cost-effectiveness
Cost-utility
Integrated disease management
Primary care
Online Access:https://doi.org/10.1186/s12962-022-00377-w

Internet

https://doi.org/10.1186/s12962-022-00377-w

Similar Items